Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson’s disease: implications for its aetiology
Etheresia Pretorius, Martin Pagé, Sthembile Mbotwe, Douglas Bruce Kell
The paper shows that LBP prevents fibrin from adopting an amyloid form induced by LPS, suggesting a link between microbial products and Parkinson’s disease.
PLoS ONE · Mar 1, 2018Peer-reviewedNeuroscience